Increased ACSL6 Expression Predicts a Favorable Prognosis in Triple-negative Breast Cancer

CONCLUSION: Altogether, the current findings highlight the potential value of ACSL6 as a diagnostic and prognostic marker in the treatment of TNBC.PMID:38310395 | DOI:10.2174/0109298673278846231222103420

Source: Current Medicinal Chemistry - February 4, 2024 Category: Chemistry Authors: Hui Hua Shuaikang Pan Haizhou Diao Yueyue Cao Xiaojun Qian Jinguo Zhang Source Type: research